Company | Date | Price Target | Rating | Analyst |
---|---|---|---|---|
10/1/2024 | $37.00 | Buy → Neutral | Citigroup | |
9/27/2024 | $37.00 | Buy → Neutral | BofA Securities | |
8/23/2024 | $38.00 → $42.00 | Overweight | JP Morgan | |
8/21/2024 | $92.00 → $94.00 | Perform | Oppenheimer | |
8/19/2024 | $37.00 → $37.00 | Overweight → Equal-Weight | Morgan Stanley | |
8/15/2024 | $76.00 → $90.00 | Sell → Neutral | UBS | |
8/14/2024 | $100.00 → $85.00 | Buy → Hold | Stifel | |
5/30/2024 | $30.00 → $32.00 | Hold | TD Cowen |
4 - HP INC (0000047217) (Issuer)
4 - Medtronic plc (0001613103) (Issuer)
4 - Medtronic plc (0001613103) (Issuer)
Citigroup downgraded HP Inc. from Buy to Neutral and set a new price target of $37.00
BofA Securities downgraded HP Inc. from Buy to Neutral and set a new price target of $37.00
JP Morgan reiterated coverage of HP Inc. with a rating of Overweight and set a new price target of $42.00 from $38.00 previously
PALO ALTO, Calif., Aug. 28, 2024 (GLOBE NEWSWIRE) -- HP (NYSE:HPQ) Third quarter GAAP diluted net earnings per share ("EPS") of $0.65, within the previously provided outlook of $0.63 to $0.77 per shareThird quarter non-GAAP diluted net EPS of $0.83, within the previously provided outlook of $0.78 to $0.92 per shareThird quarter net revenue of $13.5 billion, up 2.4% from the prior-year periodThird quarter net cash provided by operating activities of $1.4 billion, free cash flow of $1.3 billionThird quarter returned $0.9 billion to shareholders in the form of share repurchases and dividendsShare repurchase authorization increased to $10.0 billion HP Inc.'s fiscal 2024 third quarter financi
PaceMate®, a pioneer in cardiac data management and remote monitoring, announced today the acquisition of the Paceart Optima™ system, an on-premises cardiac workflow solution from Medtronic (NYSE:MDT) This strategic move significantly expands PaceMate's reach globally, adding nearly 1,000 clinic locations worldwide. This further enhances PaceMate's ability to provide the leading and most comprehensive cardiac remote monitoring solution, continuing its position as the preferred partner in advanced cardiac data management. "After a comprehensive evaluation, we are confident PaceMate is the best organization to service Paceart customers and their future cardiac data workflow needs," said Kwe
Product innovation driving growth across diversified health tech portfolio, including Automated Insulin Delivery, Transcatheter Aortic Valve Replacement, Pulsed Field Cardiac Ablation, Pain Stimulation, and Deep Brain Stimulation GALWAY, Ireland, Aug. 20, 2024 /PRNewswire/ -- Medtronic plc (NYSE:MDT) today announced financial results for its first quarter (Q1) of fiscal year 2025 (FY25), which ended July 26, 2024. Key Highlights Revenue of $7.9 billion, adjusted revenue of $8.0 billion, increased 2.8% as reported and 5.3% organicGAAP diluted earnings per share (EPS) of $0.80; non-GAAP diluted EPS of $1.23Company increases FY25 organic revenue growth and EPS guidanceMultiple franchises deliv
Abbott Laboratories (NYSE:ABT) CEO Robert Ford said the company will use a mix of TV advertisements and guerilla marketing to promote the U.S. launch of Lingo, its glucose monitoring device. This device targets consumers without diabetes, aiming to personalize health data and enhance understanding of their health metrics. Also Read: Similac Baby Formula Maker Abbott And Reckitt Face Hundreds Of Baby Formula Lawsuits. Ford projected that Lingo could become a multi-billion-dollar product, although it is still in its nascent stage. Lingo, an over-the-counter device, is scheduled to launch this year alongside Libre Rio, which received FDA clearance last month. Abbott’s consumer bi
As of July 18, 2024, three stocks in the information technology sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions. The RSI is a momentum indicator, which compares a stock’s strength on days when prices go up to its strength on days when prices go down. When compared to a stock’s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered overbought when the RSI is above 70, according to Benzinga Pro. Here's the latest list of major overbought players in this sector. IBM Common Stock (NYSE:IBM) International Business Machines is expected to repor
RBC Capital analyst Shagun Singh reiterates Medtronic (NYSE:MDT) with a Sector Perform and maintains $92 price target.
SC 13G - HP INC (0000047217) (Subject)
SC 13G/A - Medtronic plc (0001613103) (Subject)
SC 13G/A - HP INC (0000047217) (Subject)
News Highlights: Unleashes flexibility and style for freelancers and creators with HP's first 2-in-1 next-gen AI PC, the HP OmniBook Ultra FlipIntroduces the first HP EliteBook X, the world's most powerful next-gen AI business notebook1 for tech experts and business consultants, with up to an industry-leading 55 TOPS of NPU performance2Unveils innovative memory architecture that revolutionizes on-device AI, delivering lightning-fast performance for the most complex workflowsRedefines workspaces with the industry's broadest portfolio of AI-enabled multi-camera capable video conferencing solutions3Empowers on-demand performance for data scientists and AI developers with Z by HP Boost, the wor
News Highlights: HP announces the only AI platform for workstations with built-in generative AI trust for large language model (LLM) development2 to detect and correct bias in models in Z by HP AI StudioIntroducing the first HP OmniBook Ultra, the world's highest performance AI PC1 with up to an industry-leading 55 TOPS of NPU performance3Safely and securely use AI with Wolf Security on the HP OmniBook Ultra, the world's most secure consumer next gen AI PC4Explore endless possibilities with the latest AI-powered apps for productivity and content creation from Beautiful.ai, Loccus.ai, Luminar Neo, Omnibridge, Polymer, and Virtual Sapiens PALO ALTO, Calif., July 15, 2024 (GLOBE NEWSWIR
PALO ALTO, Calif., June 26, 2024 (GLOBE NEWSWIRE) -- HP Inc. (NYSE:HPQ) today announced that Karen Parkhill will join the company as Chief Financial Officer on August 5, 2024. Tim Brown, who has been serving as interim Chief Financial Officer, will return to his role as the head of Print Finance. A world-class finance leader, Parkhill, has spent the past 13 years serving as the Chief Financial Officer for well-established, publicly traded companies. Parkhill joins HP from Medtronic plc, a leading global healthcare technology company with more than 95,000 employees across 150 countries, where she served as Executive Vice President and Chief Financial Officer since 2016. "Karen
8-K - HP INC (0000047217) (Filer)
IRANNOTICE - Medtronic plc (0001613103) (Filer)
10-Q - Medtronic plc (0001613103) (Filer)
Customers are being notified of the importance of checking built-in alerts and alarms for battery status and to contact Medtronic for pump replacement if affected by this issue GALWAY, Ireland, Oct. 4, 2024 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, voluntarily issued a field action starting on July 31, 2024, notifying global customers of its MiniMed™ 600 series or 700 series insulin pumps to follow their pump's built-in alerts and alarms for battery status and to contact Medtronic if they observe changes in the battery life of their pump. Medtronic began investigating this issue upon receiving customer reports of shortened battery life and a comprehe
Dallas, Texas, Oct. 01, 2024 (GLOBE NEWSWIRE) -- GI Alliance, the nation's leading network of managed gastroenterology practices, is proud to announce a strategic and collaborative relationship with Medtronic, a global leader in healthcare technology, to deliver the opportunity to utilize Medtronic's GI Genius™ intelligent endoscopy module to the Alliance's more than 400 site locations. After a thorough evaluation of AI technologies, the GI Alliance Innovation Committee leveraged GI Genius™ as part of an internal post-marketing analysis, which included a trial at three of the Alliance's member networks and demonstrated a numerically significant improvement in polyp detection rates. This gr
APHRS: New data confirm robust long-term durability and highly efficient procedure performed without fluoroscopySuccessful launch in Japan follows recent reimbursement approval Approvals across APAC including China and Australia broaden reach for patientsGALWAY, Ireland and SYDNEY, Sept. 27, 2024 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced the presentation of clinical study results demonstrating a high rate of durable lesion formation for the PulseSelect™ Pulsed Field Ablation (PFA) System in treating atrial fibrillation (Afib). Invasive remapping conducted approximately two months post-ablation with the PulseSelect PFA System demonstr